Tolvaptan
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1744 publications
Development of Orally Disintegrating Tablets from Solid Dispersions Containing Tolvaptan/Cyclodextrin Complexes.
Journal: Turkish journal of pharmaceutical sciences
Published: April 15, 2026
Increasing Plasma Sodium with Tolvaptan Under Regulated Water Intake: Comparison with Hypertonic Saline.
Journal: American journal of physiology. Renal physiology
Published: March 26, 2026
Autosomal dominant polycystic kidney disease
Journal: Revue medicale de Liege
Published: March 12, 2026
Real-World Effectiveness of Tolvaptan for Hyponatremia in Cirrhosis Across Global Regions: A Target Trial Emulation.
Journal: JGH open : an open access journal of gastroenterology and hepatology
Published: February 13, 2026
Efficacy of Low-Dose Tolvaptan for Treatment of Profound Hyponatremia in Syndrome of Inappropriate Antidiuresis (SIAD): The EFFLUX-FLUID TRIAL.
Journal: Kidney medicine
Published: February 12, 2026
Pathogenic Pathways and Therapeutic Strategies in Autosomal Dominant Polycystic Kidney Disease (ADPKD).
Journal: Journal of cellular signaling
Published: January 29, 2026
Renal Tubule-Specific Deletion of Nephrocystin 3 (Nphp3) Causes Infantile Nephronophthisis-like Phenotypes in Mice.
Journal: International journal of molecular sciences
Published: January 18, 2026
A highly sensitive LC-MS/MS method for quantification of AB-38b in rat plasma, liver and kidney tissues: application to a pharmacokinetic study.
Journal: Analytical methods : advancing methods and applications
Published: January 12, 2026
Refractory hyponatremia in small cell lung cancer: a case report and literature review.
Journal: Frontiers in endocrinology
Published: January 04, 2026
Tolvaptan for autosomal dominant polycystic kidney disease: Real-world insights from a propensity score weighted retrospective cohort study.
Journal: American journal of nephrology
Published: December 23, 2025
The Need for Novel Therapeutic Directions in Autosomal Dominant Polycystic Kidney Disease Patient Care.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: December 05, 2025
Discovery of Non-benzoazacyclic V2R Antagonists for the Treatment of Autosomal Dominant Polycystic Kidney Disease.
Journal: Journal of medicinal chemistry
Published: November 29, 2025
Last Updated: 04/28/2026